RecruitingNot applicableNCT04944940
Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
Studying Kennedy disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Principal Investigator
- Christopher Grunseich, M.D., Pharm.DNational Institute of Neurological Disorders and Stroke (NINDS)
- Enrollment
- 70 enrolled
- Eligibility
- 18-120 years · MALE
- Timeline
- 2021 – 2026
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04944940 on ClinicalTrials.govOther trials for Kennedy disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2, PHASE3NCT06862596Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular AtrophyMasahisa Katsuno
- ACTIVE NOT RECRUITINGNCT07443449International SBMA Project (KDA)Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- RECRUITINGPHASE2NCT06169046A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular AtrophyGianni Soraru
- RECRUITINGNANCT03555578Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"Takeda
- RECRUITINGNCT05966038ALS/MND Natural History Study Data RepositoryMassachusetts General Hospital